Actinium Pharmaceuticals, Inc.

8-K Other events Jun 18, 2026 8-K Delisting notice or listing-rule failure; Regulation FD disclosure May 29, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K/A Shareholder vote results Mar 26, 2026 8-K Director or officer change Feb 13, 2026 8-K Director or officer change; Shareholder vote results Nov 26, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Changed accountants May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Director or officer change; Shareholder vote results Nov 27, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Director or officer change; Other events Nov 5, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Regulation FD disclosure Aug 5, 2024 10-Q Quarter ended 2024-03-31 Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 29, 2024 8-K Director or officer change; Shareholder vote results Dec 1, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 10-Q Quarter ended 2023-03-31 May 15, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 8-K Regulation FD disclosure Mar 10, 2023 8-K Regulation FD disclosure Feb 21, 2023 8-K Director or officer change; Shareholder vote results Dec 30, 2022 8-K Other events Dec 9, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 8-K Regulation FD disclosure Oct 31, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Entered a material agreement Jun 29, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 8-K Entered a material agreement Apr 13, 2022 10-K Fiscal year ended 2021-12-31 Mar 25, 2022 10-Q Quarter ended 2021-09-30 Nov 12, 2021 8-K Director or officer change; Shareholder vote results Nov 9, 2021 8-K Director or officer change; Regulation FD disclosure Sep 23, 2021 10-Q Quarter ended 2021-06-30 Jul 30, 2021 10-Q Quarter ended 2021-03-31 May 14, 2021